Logo image of TAC

TRANSALTA CORP (TAC) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:TAC - CA89346D1078 - Common Stock

14.06 USD
+0.06 (+0.43%)
Last: 11/26/2025, 8:05:08 PM
14.06 USD
0 (0%)
After Hours: 11/26/2025, 8:05:08 PM
Fundamental Rating

4

Overall TAC gets a fundamental rating of 4 out of 10. We evaluated TAC against 20 industry peers in the Independent Power and Renewable Electricity Producers industry. There are concerns on the financial health of TAC while its profitability can be described as average. TAC has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

TAC had positive earnings in the past year.
TAC had a positive operating cash flow in the past year.
In multiple years TAC reported negative net income over the last 5 years.
TAC had a positive operating cash flow in each of the past 5 years.
TAC Yearly Net Income VS EBIT VS OCF VS FCFTAC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

1.2 Ratios

TAC's Return On Assets of -2.17% is on the low side compared to the rest of the industry. TAC is outperformed by 65.00% of its industry peers.
Looking at the Return On Equity, with a value of -12.58%, TAC is doing worse than 65.00% of the companies in the same industry.
The Return On Invested Capital of TAC (2.51%) is comparable to the rest of the industry.
TAC had an Average Return On Invested Capital over the past 3 years of 8.64%. This is above the industry average of 4.56%.
The 3 year average ROIC (8.64%) for TAC is well above the current ROIC(2.51%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -2.17%
ROE -12.58%
ROIC 2.51%
ROA(3y)3.11%
ROA(5y)-0.07%
ROE(3y)17.47%
ROE(5y)0.34%
ROIC(3y)8.64%
ROIC(5y)N/A
TAC Yearly ROA, ROE, ROICTAC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

1.3 Margins

In the last couple of years the Profit Margin of TAC has grown nicely.
The Operating Margin of TAC (8.62%) is worse than 60.00% of its industry peers.
In the last couple of years the Operating Margin of TAC has grown nicely.
Looking at the Gross Margin, with a value of 83.57%, TAC belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
TAC's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.62%
PM (TTM) N/A
GM 83.57%
OM growth 3Y15.27%
OM growth 5Y8.46%
PM growth 3YN/A
PM growth 5Y22.94%
GM growth 3Y3.39%
GM growth 5Y-0.46%
TAC Yearly Profit, Operating, Gross MarginsTAC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), TAC is creating some value.
TAC has less shares outstanding than it did 1 year ago.
The number of shares outstanding for TAC has been increased compared to 5 years ago.
TAC has a better debt/assets ratio than last year.
TAC Yearly Shares OutstandingTAC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
TAC Yearly Total Debt VS Total AssetsTAC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

TAC has an Altman-Z score of 0.37. This is a bad value and indicates that TAC is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of TAC (0.37) is comparable to the rest of the industry.
TAC has a debt to FCF ratio of 12.69. This is a negative value and a sign of low solvency as TAC would need 12.69 years to pay back of all of its debts.
TAC has a better Debt to FCF ratio (12.69) than 85.00% of its industry peers.
TAC has a Debt/Equity ratio of 2.28. This is a high value indicating a heavy dependency on external financing.
TAC's Debt to Equity ratio of 2.28 is in line compared to the rest of the industry. TAC outperforms 55.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.28
Debt/FCF 12.69
Altman-Z 0.37
ROIC/WACC0.36
WACC6.93%
TAC Yearly LT Debt VS Equity VS FCFTAC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 0.79 indicates that TAC may have some problems paying its short term obligations.
TAC has a Current ratio (0.79) which is in line with its industry peers.
TAC has a Quick Ratio of 0.79. This is a bad value and indicates that TAC is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of TAC (0.71) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.79
Quick Ratio 0.71
TAC Yearly Current Assets VS Current LiabilitesTAC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

3

3. Growth

3.1 Past

TAC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -92.16%.
TAC shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 26.80% yearly.
TAC shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -11.00%.
Measured over the past years, TAC shows a small growth in Revenue. The Revenue has been growing by 3.92% on average per year.
EPS 1Y (TTM)-92.16%
EPS 3YN/A
EPS 5Y26.8%
EPS Q2Q%83.33%
Revenue 1Y (TTM)-11%
Revenue growth 3Y1.5%
Revenue growth 5Y3.92%
Sales Q2Q%-3.04%

3.2 Future

Based on estimates for the next years, TAC will show a very strong growth in Earnings Per Share. The EPS will grow by 22.27% on average per year.
TAC is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.70% yearly.
EPS Next Y-71.72%
EPS Next 2Y-25.75%
EPS Next 3Y-13.76%
EPS Next 5Y22.27%
Revenue Next Year-6.21%
Revenue Next 2Y-12.92%
Revenue Next 3Y-6.56%
Revenue Next 5Y-1.7%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
TAC Yearly Revenue VS EstimatesTAC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
TAC Yearly EPS VS EstimatesTAC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 2

3

4. Valuation

4.1 Price/Earnings Ratio

TAC is valuated quite expensively with a Price/Earnings ratio of 468.67.
The rest of the industry has a similar Price/Earnings ratio as TAC.
When comparing the Price/Earnings ratio of TAC to the average of the S&P500 Index (26.15), we can say TAC is valued expensively.
With a Price/Forward Earnings ratio of 64.15, TAC can be considered very expensive at the moment.
TAC's Price/Forward Earnings is on the same level as the industry average.
TAC's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 36.12.
Industry RankSector Rank
PE 468.67
Fwd PE 64.15
TAC Price Earnings VS Forward Price EarningsTAC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 200 400 600

4.2 Price Multiples

TAC's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. TAC is cheaper than 65.00% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of TAC indicates a rather cheap valuation: TAC is cheaper than 85.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 16.87
EV/EBITDA 12.38
TAC Per share dataTAC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

A cheap valuation may be justified as TAC's earnings are expected to decrease with -13.76% in the coming years.
PEG (NY)N/A
PEG (5Y)17.49
EPS Next 2Y-25.75%
EPS Next 3Y-13.76%

4

5. Dividend

5.1 Amount

TAC has a Yearly Dividend Yield of 1.33%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.61, TAC pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.41, TAC's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.33%

5.2 History

On average, the dividend of TAC grows each year by 6.10%, which is quite nice.
TAC has been paying a dividend for at least 10 years, so it has a reliable track record.
TAC has decreased its dividend in the last 3 years.
Dividend Growth(5Y)6.1%
Div Incr Years2
Div Non Decr Years2
TAC Yearly Dividends per shareTAC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

TAC has negative earnings and hence a negative payout ratio. The dividend may be in danger.
TAC's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-64.77%
EPS Next 2Y-25.75%
EPS Next 3Y-13.76%
TAC Yearly Income VS Free CF VS DividendTAC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M -400M 600M

TRANSALTA CORP

NYSE:TAC (11/26/2025, 8:05:08 PM)

After market: 14.06 0 (0%)

14.06

+0.06 (+0.43%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)11-06 2025-11-06/bmo
Earnings (Next)02-18 2026-02-18/bmo
Inst Owners71.21%
Inst Owner Change0.38%
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap4.17B
Revenue(TTM)2.48B
Net Income(TTM)-193.00M
Analysts78.95
Price Target16.49 (17.28%)
Short Float %1.16%
Short Ratio1.5
Dividend
Industry RankSector Rank
Dividend Yield 1.33%
Yearly Dividend0.29
Dividend Growth(5Y)6.1%
DP-64.77%
Div Incr Years2
Div Non Decr Years2
Ex-Date12-01 2025-12-01 (0.065)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-30.35%
Min EPS beat(2)-116.39%
Max EPS beat(2)55.69%
EPS beat(4)1
Avg EPS beat(4)-161.55%
Min EPS beat(4)-564.33%
Max EPS beat(4)55.69%
EPS beat(8)3
Avg EPS beat(8)-60.42%
EPS beat(12)6
Avg EPS beat(12)2.11%
EPS beat(16)7
Avg EPS beat(16)-18.99%
Revenue beat(2)1
Avg Revenue beat(2)-1.63%
Min Revenue beat(2)-14.2%
Max Revenue beat(2)10.93%
Revenue beat(4)3
Avg Revenue beat(4)10.43%
Min Revenue beat(4)-14.2%
Max Revenue beat(4)24.1%
Revenue beat(8)6
Avg Revenue beat(8)16.4%
Revenue beat(12)10
Avg Revenue beat(12)30.69%
Revenue beat(16)14
Avg Revenue beat(16)30.68%
PT rev (1m)21.75%
PT rev (3m)21.01%
EPS NQ rev (1m)5.29%
EPS NQ rev (3m)11.42%
EPS NY rev (1m)1.65%
EPS NY rev (3m)-34.41%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.97%
Valuation
Industry RankSector Rank
PE 468.67
Fwd PE 64.15
P/S 2.36
P/FCF 16.87
P/OCF 9.32
P/B 3.83
P/tB 7.7
EV/EBITDA 12.38
EPS(TTM)0.03
EY0.21%
EPS(NY)0.22
Fwd EY1.56%
FCF(TTM)0.83
FCFY5.93%
OCF(TTM)1.51
OCFY10.73%
SpS5.95
BVpS3.67
TBVpS1.83
PEG (NY)N/A
PEG (5Y)17.49
Graham Number1.57
Profitability
Industry RankSector Rank
ROA -2.17%
ROE -12.58%
ROCE 3.04%
ROIC 2.51%
ROICexc 2.65%
ROICexgc 3%
OM 8.62%
PM (TTM) N/A
GM 83.57%
FCFM 14.01%
ROA(3y)3.11%
ROA(5y)-0.07%
ROE(3y)17.47%
ROE(5y)0.34%
ROIC(3y)8.64%
ROIC(5y)N/A
ROICexc(3y)9.79%
ROICexc(5y)N/A
ROICexgc(3y)11.08%
ROICexgc(5y)N/A
ROCE(3y)10.46%
ROCE(5y)N/A
ROICexgc growth 3Y15.81%
ROICexgc growth 5Y18.53%
ROICexc growth 3Y15.46%
ROICexc growth 5Y17.81%
OM growth 3Y15.27%
OM growth 5Y8.46%
PM growth 3YN/A
PM growth 5Y22.94%
GM growth 3Y3.39%
GM growth 5Y-0.46%
F-Score5
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 2.28
Debt/FCF 12.69
Debt/EBITDA 4.44
Cap/Depr 49.13%
Cap/Sales 11.35%
Interest Coverage 0.75
Cash Conversion 79.95%
Profit Quality N/A
Current Ratio 0.79
Quick Ratio 0.71
Altman-Z 0.37
F-Score5
WACC6.93%
ROIC/WACC0.36
Cap/Depr(3y)120.63%
Cap/Depr(5y)98.51%
Cap/Sales(3y)23.21%
Cap/Sales(5y)22.28%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-92.16%
EPS 3YN/A
EPS 5Y26.8%
EPS Q2Q%83.33%
EPS Next Y-71.72%
EPS Next 2Y-25.75%
EPS Next 3Y-13.76%
EPS Next 5Y22.27%
Revenue 1Y (TTM)-11%
Revenue growth 3Y1.5%
Revenue growth 5Y3.92%
Sales Q2Q%-3.04%
Revenue Next Year-6.21%
Revenue Next 2Y-12.92%
Revenue Next 3Y-6.56%
Revenue Next 5Y-1.7%
EBIT growth 1Y-67.18%
EBIT growth 3Y17%
EBIT growth 5Y12.72%
EBIT Next Year63.68%
EBIT Next 3Y15.38%
EBIT Next 5Y18.02%
FCF growth 1Y-15.94%
FCF growth 3Y-2.47%
FCF growth 5Y2.59%
OCF growth 1Y-58.14%
OCF growth 3Y-7.35%
OCF growth 5Y-1.28%

TRANSALTA CORP / TAC FAQ

What is the ChartMill fundamental rating of TRANSALTA CORP (TAC) stock?

ChartMill assigns a fundamental rating of 4 / 10 to TAC.


What is the valuation status for TAC stock?

ChartMill assigns a valuation rating of 3 / 10 to TRANSALTA CORP (TAC). This can be considered as Overvalued.


What is the profitability of TAC stock?

TRANSALTA CORP (TAC) has a profitability rating of 5 / 10.


Can you provide the expected EPS growth for TAC stock?

The Earnings per Share (EPS) of TRANSALTA CORP (TAC) is expected to decline by -71.72% in the next year.


Is the dividend of TRANSALTA CORP sustainable?

The dividend rating of TRANSALTA CORP (TAC) is 4 / 10 and the dividend payout ratio is -64.77%.